Arjo P. Rutten
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Targeting histone methylation to reprogram the transcriptional state that drives survival of drug-tolerant myeloid leukemia persisters.
Journal: iScience
Published: May 13, 2022
The Novel Oral BET-CBP/p300 Dual Inhibitor NEO2734 Is Highly Effective in Eradicating Acute Myeloid Leukemia Blasts and Stem/Progenitor Cells.
Journal: HemaSphere
Published: October 14, 2020
Uncoupling DNA damage from chromatin damage to detoxify doxorubicin.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 20, 2020
IGFBP7 Induces Differentiation and Loss of Survival of Human Acute Myeloid Leukemia Stem Cells without Affecting Normal Hematopoiesis.
Journal: Cell reports
Published: March 08, 2018
Leukemic stem cell frequency: a strong biomarker for clinical outcome in acute myeloid leukemia.
Journal: PloS one
Published: May 15, 2014
Attenuation of microRNA-126 expression that drives CD34+38- stem/progenitor cells in acute myeloid leukemia leads to tumor eradication.
Journal: Cancer research
Published: January 31, 2014
Minimal residual disease detection defined as the malignant fraction of the total primitive stem cell compartment offers additional prognostic information in acute myeloid leukaemia.
Journal: International journal of laboratory hematology
Published: April 05, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026